162 related articles for article (PubMed ID: 34449178)
1. Inhibition of PI3K/Akt and ERK signaling decreases visfatin-induced invasion in liver cancer cells.
Miethe C; Torres L; Zamora M; Price RS
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):357-366. PubMed ID: 34449178
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the differential physiological effects of adipocytokines visfatin and resistin in liver cancer cells.
Miethe C; Zamora M; Torres L; Raign KG; Groll CJ; Price RS
Horm Mol Biol Clin Investig; 2019 Mar; 38(2):. PubMed ID: 30917102
[TBL] [Abstract][Full Text] [Related]
3. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
4. The differential role of resistin on invasive liver cancer cells.
Miethe C; Raign K; Zamora M; Price RS
Horm Mol Biol Clin Investig; 2023 Sep; 44(3):285-293. PubMed ID: 36867542
[TBL] [Abstract][Full Text] [Related]
5. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
[TBL] [Abstract][Full Text] [Related]
6. Visfatin Promotes Monocyte Adhesion by Upregulating ICAM-1 and VCAM-1 Expression in Endothelial Cells via Activation of p38-PI3K-Akt Signaling and Subsequent ROS Production and IKK/NF-κB Activation.
Lin YT; Chen LK; Jian DY; Hsu TC; Huang WC; Kuan TT; Wu SY; Kwok CF; Ho LT; Juan CC
Cell Physiol Biochem; 2019; 52(6):1398-1411. PubMed ID: 31075190
[TBL] [Abstract][Full Text] [Related]
7. Visfatin attenuates the ox-LDL-induced senescence of endothelial progenitor cells by upregulating SIRT1 expression through the PI3K/Akt/ERK pathway.
Ming GF; Tang YJ; Hu K; Chen Y; Huang WH; Xiao J
Int J Mol Med; 2016 Aug; 38(2):643-9. PubMed ID: 27277186
[TBL] [Abstract][Full Text] [Related]
8. The role of visfatin and resistin in an in vitro model of obesity-induced invasive liver cancer.
Miethe C; Torres L; Beristain J; Zamora M; Price RS
Can J Physiol Pharmacol; 2021 Sep; 99(9):839-846. PubMed ID: 33356858
[TBL] [Abstract][Full Text] [Related]
9. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F
Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926
[TBL] [Abstract][Full Text] [Related]
10. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.
Saxena NK; Sharma D; Ding X; Lin S; Marra F; Merlin D; Anania FA
Cancer Res; 2007 Mar; 67(6):2497-507. PubMed ID: 17363567
[TBL] [Abstract][Full Text] [Related]
11. FAM3A Protects HT22 Cells Against Hydrogen Peroxide-Induced Oxidative Stress Through Activation of PI3K/Akt but not MEK/ERK Pathway.
Song Q; Gou WL; Zhang R
Cell Physiol Biochem; 2015; 37(4):1431-41. PubMed ID: 26492522
[TBL] [Abstract][Full Text] [Related]
12. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
13. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis.
Cui Y; Lu P; Song G; Liu Q; Zhu D; Liu X
Food Chem Toxicol; 2016 Jun; 92():26-37. PubMed ID: 27032576
[TBL] [Abstract][Full Text] [Related]
14. Signaling pathways activated by PACAP in MCF-7 breast cancer cells.
Zibara K; Zeidan A; Mallah K; Kassem N; Awad A; Mazurier F; Badran B; El-Zein N
Cell Signal; 2018 Oct; 50():37-47. PubMed ID: 29935235
[TBL] [Abstract][Full Text] [Related]
15. PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells.
Alonso N; Diaz Nebreda A; Monczor F; Gutkind JS; Davio C; Fernandez N; Shayo C
Biochim Biophys Acta; 2016 Sep; 1860(9):1998-2007. PubMed ID: 27316323
[TBL] [Abstract][Full Text] [Related]
16. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.
Yang J; Zhang K; Song H; Wu M; Li J; Yong Z; Jiang S; Kuang X; Zhang T
Oncotarget; 2016 May; 7(22):32306-17. PubMed ID: 27058759
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition.
Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH; Jang HJ
Mol Biol Rep; 2021 Sep; 48(9):6231-6240. PubMed ID: 34392440
[TBL] [Abstract][Full Text] [Related]
18. Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells.
Gholinejad Z; Kheiripour N; Nourbakhsh M; Ilbeigi D; Behroozfar K; Hesari Z; Golestani A; Shabani M; Einollahi N
Peptides; 2017 Jun; 92():9-15. PubMed ID: 28442350
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways.
Li CY; Wang Q; Wang XM; Li GX; Shen S; Wei XL
Eur J Pharmacol; 2019 Dec; 864():172719. PubMed ID: 31586634
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.
Kim KY; Park KI; Kim SH; Yu SN; Park SG; Kim YW; Seo YK; Ma JY; Ahn SC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
